Published in Hepatitis Weekly, July 22nd, 2002
B.G. Peng and colleagues at the Institute of Physical and Chemical Research (RIKEN) in Japan evaluated vaccines to prevent recurrence of hepatocellular carcinoma. The investigators designed a vaccine containing cytokines encased within particles that degrade over time, providing a slow release of the cytokines rather than bolus release. Encapsulated cytokines included granulocyte-macrophage colony stimulating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly